• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

ArmaGen Technologies

edit

ArmaGen® provides platform technology solutions to the ‘blood-brain barrier’ problem, and can non-invasively target recombinant proteins, therapeutic monoclonal antibodies, and siRNA to the brain.

Recent Milestones

edit

• 
  ArmaGen Technologies received $17M in Series A funding. (11/29/12)
  Posted 12/1/12 at 5:40am via prnewswire.com
• 
  ArmaGen Technologies added James Callaway as CEO.
  Posted 1/4/13 at 7:07pm

Videos

Screenshots

edit

Above: ArmaGen Technologies
Uploaded: 12/1/12

Sources

1. ArmaGen Technologies, Inc. Announces $17 Million Series A Financing (prnewswire.com) [edit]